Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Tuesday. The firm set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS stock opened at $0.57 on Tuesday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.35. The company’s 50-day simple moving average is $0.66 and its 200-day simple moving average is $0.72. The stock has a market capitalization of $43.67 million, a price-to-earnings ratio of -5.70 and a beta of 0.97.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings results on Friday, March 29th. The company reported ($0.03) EPS for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%. The company had revenue of $2.26 million for the quarter.

Institutional Investors Weigh In On Milestone Scientific

Large investors have recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in shares of Milestone Scientific by 13.0% during the second quarter. Geode Capital Management LLC now owns 413,992 shares of the company’s stock valued at $360,000 after acquiring an additional 47,777 shares during the period. Citadel Advisors LLC increased its stake in shares of Milestone Scientific by 599.9% during the second quarter. Citadel Advisors LLC now owns 156,422 shares of the company’s stock valued at $143,000 after acquiring an additional 134,073 shares during the period. Carnegie Capital Asset Management LLC acquired a new position in shares of Milestone Scientific during the third quarter valued at approximately $121,000. State Street Corp increased its stake in shares of Milestone Scientific by 15.7% during the second quarter. State Street Corp now owns 111,585 shares of the company’s stock valued at $102,000 after acquiring an additional 15,103 shares during the period. Finally, Northern Trust Corp increased its stake in shares of Milestone Scientific by 10.8% during the second quarter. Northern Trust Corp now owns 95,193 shares of the company’s stock valued at $83,000 after acquiring an additional 9,272 shares during the period. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.